(Q45874222)

17 December 2017

title

Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury (English)

1 reference

17 December 2017

1 reference

1 reference

H J Kim

1

1 reference

17 December 2017

J S Oh

2

1 reference

17 December 2017

S S An

3

1 reference

17 December 2017

W A Pennant

4

1 reference

17 December 2017

S-J Gwak

5

1 reference

17 December 2017

A N Kim

6

1 reference

17 December 2017

P K Han

7

1 reference

17 December 2017

D H Yoon

8

1 reference

17 December 2017

K N Kim

9

1 reference

17 December 2017

Y Ha

10

1 reference

17 December 2017

publication date

20 October 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

513-521

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2011.137

exact match

0 references

cites work

Stem cell therapy for spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Stem and progenitor cell-based therapy of the human central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

21 January 2018

Nerve root replantation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Stem cells for the treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Evaluation of human fetal neural stem/progenitor cells as a source for cell replacement therapy for neurological disorders: properties and tumorigenicity after long-term in vitro maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Regional energy metabolism following short-term neural stem cell transplantation into the injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Co-transplantation of neural stem cells and NT-3-overexpressing Schwann cells in transected spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Combined treatment of neurotrophin-3 gene and neural stem cells is propitious to functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Granulocyte macrophage-colony stimulating factor activates microglia in rat cortex organotypic brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

A region within the 5'-untranslated region of hypoxia-inducible factor-1alpha mRNA mediates its turnover in lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulosa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

A new model of retinal photoreceptor cell degeneration induced by a chemical hypoxia-mimicking agent, cobalt chloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Oxidative stress and neurodegeneration: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

GM-CSF regulates the ERK1/2 pathways and protects injured retinal ganglion cells from induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

Stem cell-based therapies for spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

7 January 2021

Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

7 January 2021

Cobalt chloride, a hypoxia-mimicking agent, targets sterol synthesis in the pathogenic fungus Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

7 January 2021

The impact of microglia-derived cytokines upon gliosis in the CNS

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.137

7 January 2021

Identifiers

DOI

10.1038/GT.2011.137

1 reference

17 December 2017

Dimensions Publication ID

1033065240

0 references

1 reference

17 December 2017